(Q44282612)

English

A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation

scientific article published on 25 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

based on heuristic

inferred from title

11

object named as

P Ljungman

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

10

object named as

J Mattsson

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

O Ringdén

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

T Erkers

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

J Aschan

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

K Garming-Legert

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

K Le Blanc

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

H Hägglund

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

B Omazic

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

P Svenberg

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

G Dahllöf

9

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

M Remberger

12

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

25 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Journal of Internal Medicine

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

274

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

153-162

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12056

21 January 2018

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective s

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12056

21 January 2018

Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12056

21 January 2018

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12056

21 January 2018

Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12056

21 January 2018

Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12056

21 January 2018

Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12056

21 January 2018

Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12056

21 January 2018

Pathophysiologic mechanisms of acute graft-vs.-host disease

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12056

21 January 2018

Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12056

21 January 2018

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12056

21 January 2018

Identifiers

10.1111/JOIM.12056

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44282612&oldid=2140791592"